The GAVI Alliance (formerly the Global Alliance for Vaccines and Immunisation) is a public-private global health partnership committed to increasing access to immunisation in poor countries.
The GAVI Alliance was launched in 2000, at a time when the distribution of vaccines to children in the poorest parts of the world had begun to falter. By the end of the 1990s, immunisation rates were stagnating or even declining.
Since its launch in 2000, the GAVI Alliance has, contributed to the immunisation of an additional 370 million children, helping developing countries prevent more than 5.5 million future deaths from Hepatitis B, Haemophilus Influenza type B (Hib), Measles, Pertussis, Pneumococcal disease, Polio, Rotavirus Diarrhoea and yellow fever.
In July 2013, GAVI received a $700 million bond to purchase vaccines to fight pneumonia and diarrhea, which are two of the most frequent killers of children under the age of five. GAVI will also purchase vaccines for diphtheria, tetanus, pertussis, HIB and hepatitis B. The bond issue will fund immunization efforts supported by GAVI. The transaction was done by the International Finance Facility for Immunisation. Jim Yong Kim, president of the World Bank Group, which is IFFI’s treasury manager, said that having predictable, long-term funding in place will help them ensure that the world’s most vulnerable children have access to healthcare, and that is a critical step in achieving the goal of ending extreme poverty by 2030.
In Pakistan, GAVI Alliance is funding to fill the existing gaps in the health sector including immunisation, maternal and child health care and health system strengthening.
Pakistan is one of the ten pilot countries successfully implementing this support through a consortium of 15 CSOs working in selected districts of Punjab, Sindh, Khyber Pakhtunkhwa, Balochistan, AJK and Gilgit Baltistan. Since September 2009, CSOs are implementing their respective assignments and reporting to GAVI CSO Support Unit Pakistan.